Search results for abx831212
Showing 1 – 10 of1products
ID: BAB112039743
Icrucumab, Abbexa, abx831212
Icrucumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting FLT1/VEGFR-1, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Request a product
Please provide the required information below so that we can quickly source your products.